Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Drug–drug interaction between clobazam and cannabidiol (GWP42003-P) in adults with severe myoclonic epilepsy of infancy
2014-002942-33Phase 2Completed
- Sponsor
- GW Pharmaceuticals
- Start
- Feb 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in myoclonic epilepsy of infancy (MEI) comparing Cannabidiol + clobazam with Placebo + clobazam (2 arms). Primary endpoint: Pharmacokinetic parameters of clobazam and N-desmethylclobazam. Started Feb 2015; status: completed.
02
Drugs
cannabidiol
03
Conditions
myoclonic epilepsy of infancy (MEI)
Beyond the preview
Go deeper on 2014-002942-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-002942-33.